CGP 52432: a novel potent and selective GABAB autoreceptor antagonist in rat cerebral cortex

https://doi.org/10.1016/0014-2999(93)90268-MGet rights and content

Abstract

As previously reported GABAB receptors are heterogeneous. Three pharmacologically distinct receptor subtypes mediating inhibition of γ-aminobutyric acid (GABA), glutamate or somatostatin release, respectively, exist on axon terminals of rat cerebral cortex. We investigated the novel GABAB receptor antagonist, [3-[[(3,4-dichlorophenyl)methyl]amino]propyl](diethoxy-methyl) phosphinic acid (CGP 52432), on the above receptor subtypes. The effects of (−)-baclofen on the K+-evoked release of GABA, glutamate or somatostatin from rat cortical synaptosomes were antagonized by CGP 52432. The IC50 of the drug at GABA autoreceptors (0.085 μM) was 35- and 100-fold lower than at the receptors regulating somatostatin and glutamate overflow, respectively. At the autoreceptor the calculated pA2 for CGP 52432 amounted to 7.70, which makes the drug about 1000-fold more potent than phaclofen at this receptor. The potency and selectivity characteristics of CGP 52432 indicate that the drug is by far the most appropriate tool to investigate the terminal GABAB autoreceptors of the rat cerebral cortex.

References (21)

There are more references available in the full text version of this article.

Cited by (63)

  • Gut-joint axis: Oral Probiotic ameliorates Osteoarthritis

    2024, Journal of Traditional and Complementary Medicine
  • Disinhibition reduces extracellular glutamine and elevates extracellular glutamate in rat hippocampus in vivo

    2015, Epilepsy Research
    Citation Excerpt :

    Other possible effects of GABABR blockade include (a) effect on presynaptic GABA autoreceptor, (b) antagonism of postsynaptic membrane hyperpolarization and the late inhibitory postsynaptic potential in pyramidal neurons (Olpe et al., 1990) and (c) elevation of cGMP mediated by the glutamate receptor/NO synthetase/guanylyl cyclase pathway (Fedele et al., 1997). In the present study, the effect on presynaptic GABA autoreceptor is likely to be small, because CGP 35348 is a weak blocker of GABA autoreceptor (Lanza et al., 1993). Also, elevation of cGMP is likely to be quite minor because CGP 35348 was delivered in aCSF containing normal (0.8 mM) Mg2+.

  • GABA <inf>B</inf> receptor-mediated selective peripheral analgesia by the non-proteinogenic amino acid, isovaline

    2012, Neuroscience
    Citation Excerpt :

    Whereas isovaline produced a locally restricted anti-allodynic effect at 5 μmol, we did not observe a locally restricted decrease in mechanical hypersensitivity at the doses tested for GABA or baclofen. The selective GABAB receptor antagonist, CGP52432 (Lanza et al., 1993), blocked the analgesic effects induced by near maximally effective doses of isovaline, GABA, or baclofen (Fig. 1B). Injected prior to PGE2 alone, CGP52432 did not increase PGE2-induced sensitivity.

  • GABA <inf>B</inf> receptors accentuate neural excitation contrast in rat insular cortex

    2011, Neuroscience
    Citation Excerpt :

    If these GABAB receptors were spontaneously activated, CGP 52432 should increase responsivity to the first stimulus by removing GABAB receptor-mediated suppression of glutamate release. In contrast, GABAB receptors may suppress spontaneous GABA release from inhibitory presynaptic terminals via autoreceptors (Lanza et al., 1993; Bailey et al., 2004; Takesian et al., 2010), as CGP 52432 sharpened the decay trajectory of responsivity to the first stimulus (Tseng and Haberly, 1988; McCormick, 1989; Fig. 4D). This explanation is supported by a report that rapid perfusion of a GABAB receptor antagonist increases the first inhibitory postsynaptic currents recorded from hippocampal cell pairs (Jensen et al., 1999).

  • Behavioral analyses of GHB: Receptor mechanisms

    2009, Pharmacology and Therapeutics
View all citing articles on Scopus
View full text